XORTX Therapeutics Statistics
Total Valuation
XRTX has a market cap or net worth of $2.94 million. The enterprise value is $811,300.
Important Dates
The last earnings date was Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
XRTX has 3.48 million shares outstanding. The number of shares has increased by 36.17% in one year.
| Current Share Class | 3.48M |
| Shares Outstanding | 3.48M |
| Shares Change (YoY) | +36.17% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 3.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.38 |
| P/TBV Ratio | 1.51 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.22, with a Debt / Equity ratio of 0.03.
| Current Ratio | 6.22 |
| Quick Ratio | 5.97 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -17.92% and return on invested capital (ROIC) is -42.68%.
| Return on Equity (ROE) | -17.92% |
| Return on Assets (ROA) | -33.81% |
| Return on Invested Capital (ROIC) | -42.68% |
| Return on Capital Employed (ROCE) | -81.94% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$245,552 |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.63% in the last 52 weeks. The beta is -0.21, so XRTX's price volatility has been lower than the market average.
| Beta (5Y) | -0.21 |
| 52-Week Price Change | -69.63% |
| 50-Day Moving Average | 1.06 |
| 200-Day Moving Average | 1.61 |
| Relative Strength Index (RSI) | 34.99 |
| Average Volume (20 Days) | 45,678 |
Short Selling Information
The latest short interest is 24,486, so 0.70% of the outstanding shares have been sold short.
| Short Interest | 24,486 |
| Short Previous Month | 92,933 |
| Short % of Shares Out | 0.70% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 0.02 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.84M |
| Pretax Income | -3.34M |
| Net Income | -736,657 |
| EBITDA | -2.85M |
| EBIT | -2.84M |
| Earnings Per Share (EPS) | -$0.29 |
Full Income StatementBalance Sheet
The company has $2.30 million in cash and $61,468 in debt, giving a net cash position of $2.24 million or $0.64 per share.
| Cash & Cash Equivalents | 2.30M |
| Total Debt | 61,468 |
| Net Cash | 2.24M |
| Net Cash Per Share | $0.64 |
| Equity (Book Value) | 2.13M |
| Book Value Per Share | 0.73 |
| Working Capital | 2.02M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$4.09 million and capital expenditures -$1, giving a free cash flow of -$4.09 million.
| Operating Cash Flow | -4.09M |
| Capital Expenditures | -1 |
| Free Cash Flow | -4.09M |
| FCF Per Share | -$1.17 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |